1. Home
  2. CORT vs VFS Comparison

CORT vs VFS Comparison

Compare CORT & VFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • VFS
  • Stock Information
  • Founded
  • CORT 1998
  • VFS 2017
  • Country
  • CORT United States
  • VFS Vietnam
  • Employees
  • CORT N/A
  • VFS N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • VFS Blank Checks
  • Sector
  • CORT Health Care
  • VFS Finance
  • Exchange
  • CORT Nasdaq
  • VFS Nasdaq
  • Market Cap
  • CORT 7.5B
  • VFS 8.2B
  • IPO Year
  • CORT N/A
  • VFS N/A
  • Fundamental
  • Price
  • CORT $69.15
  • VFS $3.50
  • Analyst Decision
  • CORT Strong Buy
  • VFS Buy
  • Analyst Count
  • CORT 4
  • VFS 3
  • Target Price
  • CORT $142.00
  • VFS $5.75
  • AVG Volume (30 Days)
  • CORT 856.9K
  • VFS 516.7K
  • Earning Date
  • CORT 08-05-2025
  • VFS 09-19-2025
  • Dividend Yield
  • CORT N/A
  • VFS N/A
  • EPS Growth
  • CORT 8.36
  • VFS N/A
  • EPS
  • CORT 1.14
  • VFS N/A
  • Revenue
  • CORT $685,446,000.00
  • VFS $2,103,991,902.00
  • Revenue This Year
  • CORT $35.85
  • VFS N/A
  • Revenue Next Year
  • CORT $35.22
  • VFS $40.04
  • P/E Ratio
  • CORT $60.53
  • VFS N/A
  • Revenue Growth
  • CORT 30.93
  • VFS 65.72
  • 52 Week Low
  • CORT $32.33
  • VFS $2.56
  • 52 Week High
  • CORT $117.33
  • VFS $5.38
  • Technical
  • Relative Strength Index (RSI)
  • CORT 45.05
  • VFS 46.58
  • Support Level
  • CORT $67.44
  • VFS $3.53
  • Resistance Level
  • CORT $73.78
  • VFS $3.68
  • Average True Range (ATR)
  • CORT 2.08
  • VFS 0.08
  • MACD
  • CORT -0.31
  • VFS -0.01
  • Stochastic Oscillator
  • CORT 26.97
  • VFS 23.40

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About VFS VinFast Auto Ltd.

VinFast Auto Ltd manufactures cars, and motor vehicles, renders leasing activities, trades smartphones, and related businesses. The company is engaged in designing and manufacturing premium EVs, e-scooters, and e-buses. The company's initial EV product line is an all-new range of fully electric A- through E-segment SUVs. The Company has three reportable segments, namely Car, E-scooter and Ebus. The Car segment includes the design, development, manufacturing and sales of cars and related battery lease and battery charging services for cars. The E-scooter segment includes the design, development, manufacturing and sales of e-scooters and related battery lease and battery charging service for e-scooters. The Ebus segment includes the design, development, manufacturing and sales of Ebus.

Share on Social Networks: